Thyroid hormone replacement therapy in dialysis/renal insufficiency patients

被引：1
|
作者：
Zhao, Xiaolu [1 ]
Liu, Fan [2 ,3 ]
Yuan, Saiya [2 ,3 ]
Wang, Fei [2 ,3 ]
Li, Chunyu [2 ,3 ]
Guo, Congcong [2 ,3 ]
Zhao, Junyu [2 ,3 ]
机构：
[1] Shandong Second Med Univ, Sch Clin Med, Weifang, Peoples R China
[2] Shandong First Med Univ, Affiliated Hosp 1, Jinan, Peoples R China
[3] Shandong First Med Univ, Shandong Prov Qianfoshan Hosp, Shandong Inst Nephrol, Shandong Key Lab Rheumat Dis & Translat Med, Jinan, Peoples R China
来源：
FRONTIERS IN ENDOCRINOLOGY | 2025年 / 16卷
基金：
中国国家自然科学基金;
关键词：
dialysis; renal insufficiency; thyroid hormone; replacement therapy; levothyroxine; DIABETIC-NEPHROPATHY PATIENTS; KIDNEY-DISEASE PATIENTS; RENAL-FUNCTION; SUBCLINICAL HYPOTHYROIDISM; DOUBLE-BLIND; L-THYROXINE; SOY FORMULA; LEVOTHYROXINE; ABSORPTION; PREVALENCE;
D O I：
10.3389/fendo.2025.1540802
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Dialysis/renal insufficiency patients are often accompanied by hypothyroidism due to renal damage, the mechanisms of which are complex. The use of thyroid hormone replacement therapy in such patients has become an important clinical issue. This article reviews the mechanism of hypothyroidism in dialysis/renal insufficiency patients and describes the importance and precautions of thyroid hormone replacement therapy to provide a reference for clinical diagnosis and treatment.
引用
收藏
页数：9
相关论文
共 50 条
  • [31] Drug therapy in patients with renal insufficiency
    Reactions Weekly, 1997, 644 (1) : 3 - 3
  • [32] Dyslipidemia and risk of renal replacement therapy or death in incident pre-dialysis patients
    Voskamp, Pauline W. M.
    van Diepen, Merel
    Dekker, Friedo W.
    Hoogeveen, Ellen K.
    SCIENTIFIC REPORTS, 2018, 8
  • [33] The renal replacement therapy landscape in 2030: reducing the global cardiovascular burden in dialysis patients
    Canaud, Bernard
    Collins, Allan
    Maddux, Frank
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2020, 35 : 51 - 57
  • [34] The Challenges and Complexities of Thyroid Hormone Replacement
    Kansagra, Shayri M.
    McCudden, Christopher R.
    Willis, Monte S.
    LABMEDICINE, 2010, 41 (06): : 338 - 348
  • [35] Differentiated thyroid cancer: a focus on post-operative thyroid hormone replacement and thyrotropin suppression therapy
    Benjamin J. Gigliotti
    Sina Jasim
    Endocrine, 2024, 83 : 251 - 258
  • [36] Differentiated thyroid cancer: a focus on post-operative thyroid hormone replacement and thyrotropin suppression therapy
    Gigliotti, Benjamin J.
    Jasim, Sina
    ENDOCRINE, 2024, 83 (02) : 251 - 258
  • [37] Pharmacokinetics of L-Triiodothyronine in Patients Undergoing Thyroid Hormone Therapy Withdrawal
    Van Tassell, Benjamin
    Wohlford, George F.
    Linderman, Joyce D.
    Smith, Sheila
    Yavuz, Sahzene
    Pucino, Frank
    Celi, Francesco S.
    THYROID, 2019, 29 (10) : 1371 - 1379
  • [38] Suboptimal Thyroid Hormone Replacement Is Associated With Worse Hospital Outcomes
    Ettleson, Matthew D.
    Bianco, Antonio C.
    Wan, Wen
    Laiteerapong, Neda
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2022, 107 (08) : E3411 - E3419
  • [39] First dialysis in Australia and Queensland experiences of renal replacement therapy
    Petrie, James J. B.
    RENAL SOCIETY OF AUSTRALASIA JOURNAL, 2009, 5 (02) : 57 - 58
  • [40] Determinants for Thyroid Hormone Replacement Therapy in Subclinical Hypothyroidism: A Multicenter Electronic Health Records-Based Study
    Toloza, Freddy J. K.
    El Kawkgi, Omar M. M.
    Spencer, Horace J. J.
    Mathews, Sherin Elsa
    Garcia, Andrea
    Gamboa, Augusto
    Mirza, Nabeel
    Mohan, Sneha
    Vallejo, Sebastian
    Bogojevic, Marija
    Rodriguez-Gutierrez, Rene
    Ospina, Naykky M. Singh M.
    Brito, Juan P. P.
    Maraka, Spyridoula
    THYROID, 2023, 33 (09) : 1045 - 1054
12345